Almac devises test to detect likelihood of colon cancer recurring
Professor Paul Harkin, President and Managing Director of Almac's Diagnostic business unit which has devised a new test to detect likelihood of colon cancer recurring.
A new study has revealed that colonoscopy screenings to detect colon cancer may not be as accurate as previously thought.